Authors: van der Linden, MW van Lopik, T Aarden, LA Westendorp, RGJ Huizinga, TWJ

Citation: Mw. Van Der Linden et al., Soluble CD95 concentrations are increased in patients with severe systemiclupus erythematosus, but not in their first degree relatives, ANN RHEUM D, 60(3), 2001, pp. 237-241

Authors: Ferreira, CG Tolis, C Span, SW Peters, GJ van Lopik, T Kummer, AJ Pinedo, HM Giaccone, G

Citation: Cg. Ferreira et al., Drug-induced apoptosis in lung cancer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway, CLIN CANC R, 6(1), 2000, pp. 203-212

Authors: van Lopik, T Bijl, M Hart, M Boeije, L Gesner, T Creasy, AA Kallenberg, CGM Aarden, LA Smeenk, RJT Smeenk, JT

Citation: T. Van Lopik et al., Patients with systemic lupus erythematosus with high plasma levels of sFasrisk relapse, J RHEUMATOL, 26(1), 1999, pp. 60-67

Authors: Rep, MHG Schrijver, HM van Lopik, T Hintzen, RQ Roos, MTL Ader, HJ Polman, CH van Lier, RAW

Citation: Mhg. Rep et al., Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients, J NEUROIMM, 96(1), 1999, pp. 92-100